Related Experiment Video
Updated: Jun 9, 2026
06:57
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
Human papillomavirus DNA testing for cervical cancer screening: practical aspects in developing countries
Suzanne E Belinson1, Jerome L Belinson
1Preventive Oncology International, Inc., Cleveland Heights, Ohio 44118, USA. seb@poiinc.org
Molecular Diagnosis & Therapy
|August 31, 2010
Summary
Human papillomavirus (HPV) DNA testing offers a valuable strategy for cervical cancer screening in developing nations. This review explores practical implementation and delivery solutions for HPV testing to overcome regional challenges.
Area of Science:
- Gynecology
- Oncology
- Public Health
Background:
- Cervical cancer is a leading cause of cancer death in women globally, particularly in developing regions.
- It is the only preventable gynecologic cancer through screening, yet current methods in the Western world are suboptimal.
- Developing countries face unique challenges in establishing effective cervical cancer screening programs.
Purpose of the Study:
- To review the practical aspects of implementing and delivering human papillomavirus (HPV) DNA testing as a primary cervical cancer screening strategy.
- To identify and propose solutions for real-world challenges in the developing world.
Main Methods:
- This is a review article, synthesizing existing literature and expert knowledge.
- Focuses on the implementation and delivery of HPV DNA testing in resource-limited settings.
Main Results:
- HPV DNA testing is a valuable tool due to its association with cervical cancers.
- The review addresses practical implementation challenges specific to developing countries.
Conclusions:
- Implementing HPV DNA testing as a primary screening strategy can significantly impact cervical cancer burden in developing nations.
- Addressing practical challenges is crucial for successful program delivery and improved women's health outcomes.
